• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Abiomed sues Maquet over Impella patents

Abiomed sues Maquet over Impella patents

July 12, 2016 By Brad Perriello

Abiomed, MaquetThreatened with a patent infringement lawsuit if it didn’t agree to a licensing deal with Maquet, Abiomed (NSDQ:ABMD) responded by asking a Massachusetts judge for a judgment of non-infringement last May.

Maquet, a division of Getinge (PINK:GETI B), sent a letter to Danvers, Mass.-based Abiomed in December 2015, alleging infringement of a trio of patents by the Impella line of transcatheter heart pumps and seeking a licensing deal – and threatening a patent infringement action in the alternative.

“We understand that Abiomed’s marketing efforts have targeted Maquet’s products as competing devices. Maquet has not been required to mark the patent information on its products because they are different from the patent claims. Thus, in the event of an infringement dispute Maquet could seek lost profits damages for up to the past 6 years, plus injunctive relief requiring Abiomed to stop making, using, offering for sale, selling or importing its Impella products for the remaining patent term,” Maquet Cardiovascular managing director Ajey Atre wrote in a Dec. 15, 2015, letter. “A preliminary draft of a complaint for patent infringement is attached. Notwithstanding the foregoing facts, Maquet is willing to discuss entering into an agreement with Abiomed for a license to some or all of the Maquet patent portfolio. Please consider this letter as an invitation to discuss reasonable terms of a business arrangement that we hope would be attractive to both Maquet and Abiomed.”

In a Jan. 19 response, a lawyer for Abiomed said the Maquet patent claims were “devoid of any merit” and denied any infringement.

“Indeed, not only are Maquet’s patents not infringed by Abiomed or its Impella products, the asserted claims of those patents are invalid and unenforceable, as set forth in detail below. Clearly, Maquet failed to perform an adequate and appropriate investigation before lobbing its irresponsible claims of infringement at Abiomed,” attorney Richard McCaulley Jr. wrote. “Abiomed has deep respect for patent rights, but it will not take a license to patents that it does not use, that are invalid and cover only technology that Abiomed developed first, and that are unenforceable. We trust this letter resolves any questions or concerns Maquet has with respect to Abiomed’s Impella products.”

“Maquet is confident that its patent rights are valid and enforceable, that Abiomed infringes, and that Abiomed should seek a license from Maquet. At this time, Maquet remains open to a discussion with Abiomed for the purpose of finding a reasonable business solution to this dispute. Please advise by close of business on Friday, May 20, 2016 if Abiomed is interested in meeting to try to resolve this matter without litigation,” came the May 3 response from Maquet lawyer Michael Connor.

Abiomed filed its lawsuit May 19 in the U.S. District Court for Massachusetts, asking Judge Dennis Saylor to rule that it’s not infringing any of the patents.

“To resolve the legal and factual questions raised by Abiomed and to afford relief from uncertainty and controversy which Maquet’s accusations have precipitated, Abiomed is entitled to a declaratory judgment that Abiomed has not infringed, and is not infringing, any claim” of any of the 3 patents, Abiomed claimed the complaint.

Filed Under: Legal News, Patent Infringement, Structural Heart Tagged With: Abiomed, Getinge, Maquet Cardiovascular LLC

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy